Insider · CIK 0001239241
EVNIN ANTHONY B
Reports to the SEC for 13 companies · NEW YORK, NY
Transactions
50
Companies
13
Filings
7
CIK
0001239241
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-01-19 | AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-01-19 | AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-01-19 | AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-01-19 | AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-01-19 | AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-01-19 | AVEO PHARMACEUTICALS, INC.D Disposition to Issuer | −$628K |
| 2023-01-19 | AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-01-19 | AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-01-19 | AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-01-19 | AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-01-19 | AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-01-19 | AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-06-16 | INFINITY PHARMACEUTICALS, INC.A Award | +$31.5K |
| 2022-06-16 | INFINITY PHARMACEUTICALS, INC.Stock Option(right to buy)A Award | — |
| 2022-06-07 | AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award | — |
| 2021-06-10 | INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award | — |
| 2021-06-10 | INFINITY PHARMACEUTICALS, INC.A Award | +$10.5K |
| 2021-06-09 | AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award | — |
| 2021-06-02 | CANTEL MEDICAL LLCD Disposition to Issuer | −$978K |
| 2020-07-31 | CANTEL MEDICAL LLCA Award | — |
| 2020-06-17 | INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award | — |
| 2020-06-17 | INFINITY PHARMACEUTICALS, INC.A Award | — |
| 2020-06-10 | AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award | — |
| 2020-03-26 | CANTEL MEDICAL LLCP Purchase | +$48.4K |
| 2020-03-26 | CANTEL MEDICAL LLCP Purchase | +$48.6K |
| 2019-12-13 | CONSTELLATION PHARMACEUTICALS INCP Purchase | +$13.8M |
| 2019-10-03 | CONSTELLATION PHARMACEUTICALS INCP Purchase | +$24M |
| 2019-07-31 | CANTEL MEDICAL LLCA Award | — |
| 2019-06-13 | INFINITY PHARMACEUTICALS, INC.A Award | +$21K |
| 2019-06-13 | INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award | — |
| 2019-06-12 | AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award | — |
| 2019-06-06 | CONSTELLATION PHARMACEUTICALS INCStock Option (right to buy)A Award | — |
| 2018-11-21 | AVEO PHARMACEUTICALS, INC.P Purchase | +$223.439 |
| 2018-11-16 | AVEO PHARMACEUTICALS, INC.S Sale | −$274K |
| 2018-11-15 | AVEO PHARMACEUTICALS, INC.S Sale | −$1.25M |
| 2018-11-14 | AVEO PHARMACEUTICALS, INC.S Sale | −$618K |
| 2018-07-31 | CANTEL MEDICAL LLCA Award | — |
| 2018-07-23 | CONSTELLATION PHARMACEUTICALS INCSeries A Preferred StockC Conversion | — |
| 2018-07-23 | CONSTELLATION PHARMACEUTICALS INCP Purchase | +$2M |
| 2018-07-23 | CONSTELLATION PHARMACEUTICALS INCSeries E Preferred StockC Conversion | — |
| 2018-07-23 | CONSTELLATION PHARMACEUTICALS INCC Conversion | — |
| 2018-07-23 | CONSTELLATION PHARMACEUTICALS INCSeries F Preferred StockC Conversion | — |
| 2018-07-23 | CONSTELLATION PHARMACEUTICALS INCSeries B Preferred StockC Conversion | — |
| 2018-07-23 | CONSTELLATION PHARMACEUTICALS INCSeries D Preferred StockC Conversion | — |
| 2018-07-23 | CONSTELLATION PHARMACEUTICALS INCSeries E-1 Preferred StockC Conversion | — |
| 2018-06-18 | AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award | — |
| 2018-06-12 | INFINITY PHARMACEUTICALS, INC.A Award | +$20K |
| 2018-06-12 | INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award | — |
| 2018-06-12 | INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award | — |
| 2018-03-05 | Juno Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer | −$324K |
Recent filings
- 4EVNIN ANTHONY B0000899243-23-002193SEC(opens sec.gov)
- 4EVNIN ANTHONY B0001140361-22-023338SEC(opens sec.gov)
- 4EVNIN ANTHONY B0001628280-22-016605SEC(opens sec.gov)
- 4EVNIN ANTHONY B0001140361-21-020643SEC(opens sec.gov)
- 4EVNIN ANTHONY B0000899243-21-022797SEC(opens sec.gov)
- 4EVNIN ANTHONY B0001104659-21-075850SEC(opens sec.gov)
- 4EVNIN ANTHONY B0000019446-20-000050SEC(opens sec.gov)
Companies
- ACCELERON PHARMA INCDirector
- AVEO PHARMACEUTICALS, INC.Director
- CANTEL MEDICAL LLCDirector
- Coley Pharmaceutical Group, Inc.Director, 10% Owner
- CONSTELLATION PHARMACEUTICALS INCDirector
- ICAGEN INCDirector
- INFINITY PHARMACEUTICALS, INC.Director
- Juno Therapeutics, Inc.Director
- MEMORY PHARMACEUTICALS CORPDirector
- OTIX GLOBAL, INC.Director
- PHARMOS CORPDirector, 10% Owner
- RENOVIS INCDirector
- Viracta Therapeutics, Inc.DirectorVIRX
Address
C/O VENROCK 530 FIFTH AVENUE, 22ND FLOOR
NEW YORK, NY, 10036